Back to Search
Start Over
Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer:Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study
- Source :
- Coleman, R L, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Rangwala, R, Vindeløv, S D, Chen, M, Harris, J R, Nicacio, L, Teng, M S L, Smith, M, Monk, B J & Vergote, I B 2020, ' Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study ', Annals of Oncology, vol. 31, no. Suppl. 4, pp. S1162-S1163 . https://doi.org/10.1016/j.annonc.2020.08.2262
- Publication Year :
- 2020
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Coleman, R L, Lorusso, D, Gennigens, C, González-Martín, A, Randall, L, Cibula, D, Lund, B, Woelber, L, Pignata, S, Forget, F, Redondo, A, Rangwala, R, Vindeløv, S D, Chen, M, Harris, J R, Nicacio, L, Teng, M S L, Smith, M, Monk, B J & Vergote, I B 2020, ' Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer : Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study ', Annals of Oncology, vol. 31, no. Suppl. 4, pp. S1162-S1163 . https://doi.org/10.1016/j.annonc.2020.08.2262
- Accession number :
- edsair.dedup.wf.001..3907c117279139277496a33567601149